New evaluation agreement with large global pharma company
Nanexa has announced today that it has signed a new Material Transfer and Feasibility Study Agreement agreement with a large global pharmaceutical company (company undisclosed). The agreement is to evaluate PharmaShell in a depot formulation of a monoclonal antibody.